ai discovery
30 articles about ai discovery in AI news
Inference Beauty Today Announces Global Platform Expansion, Powering Personalized Beauty Discovery for 100+ Retailers and Brands
Inference Beauty Today has expanded its AI-powered personalized beauty discovery platform globally, now serving over 100 retailers and brands across five markets. This signals the maturation of specialized, third-party AI recommendation engines in the beauty and personal care sector.
Mediagenix Enhances Content Personalization with AI Semantic Search for Better Discovery
Media technology company Mediagenix has integrated AI-powered semantic search into its content management platform to improve content discovery and personalization for broadcasters and media companies. This represents a practical application of embedding technology in the media sector.
Revieve Launches AI Skin Advisor for ChatGPT, Expanding Generative AI Beauty Discovery
Beauty tech platform Revieve launches an AI Skin Advisor as a ChatGPT plugin, enabling conversational skin analysis and product discovery. This represents a strategic expansion into generative AI platforms for beauty brands and retailers.
AI Shopping Update: OpenAI Focuses on Discovery, Meta Launches Checkout & Shopify Offers Catalog Integration
A trio of major AI shopping announcements: OpenAI shifts focus to product discovery, Meta launches in-app checkout for AI shopping ads, and Shopify opens its catalog integration to any brand. This signals a rapid move from conversational AI to transactional agentic systems.
The Intent-Source Divide: How AI Search Queries Shape Hotel Discovery
A new arXiv study audits Google Gemini's hotel recommendations in Tokyo, finding a 25.1 percentage-point gap in citations between experiential and transactional queries. This 'Intent-Source Divide' suggests AI search may reduce reliance on Online Travel Agencies (OTAs) for discovery.
AI Accelerates Genomic Discovery, Unlocking '7 Years of Potential in 30 Minutes'
An AI science-research technology is reportedly accelerating discovery in genomics at an unprecedented rate, described as unlocking seven years of potential work in just thirty minutes.
Best Buy Partners with Google to Integrate Product Catalog into AI-Powered Discovery
Best Buy is partnering with Google to enable direct purchasing within AI search and Gemini, positioning itself as a hub for AI hardware discovery. This move responds to flat revenue and aims to capture new digital shopping behaviors.
From Code to Discovery: The Next Frontier of AI Agents in Research
AI researcher Omar Saray predicts a shift from 'agentic coding' to 'agentic research'—where AI systems will autonomously conduct scientific discovery. This evolution promises to accelerate innovation across disciplines.
AI Bridges the Gap Between Data and Discovery: New Framework Aligns Scientific Observations with Decades of Literature
Researchers have developed a novel AI framework that aligns X-ray spectra with scientific literature using contrastive learning. This multimodal approach improves physical variable estimation by 16-18% and identifies high-priority astronomical targets, demonstrating how AI can accelerate scientific discovery by connecting data with domain knowledge.
Beyond Keywords: How Google's AI Mode Revolutionizes Visual Discovery for Luxury Retail
Google's AI Mode uses advanced multimodal AI to understand the intent behind visual searches. For luxury brands, this means customers can find products using complex, subjective descriptions, unlocking a new frontier in visual commerce and inspiration-based discovery.
Beyond General AI: How Liquid Foundation Models Are Revolutionizing Drug Discovery
Researchers have developed MMAI Gym, a specialized training platform that teaches AI the 'language of molecules' to create more efficient drug discovery models. The resulting Liquid Foundation Models outperform larger general-purpose AI while requiring fewer computational resources.
Beyond Chatbots: How Self-Evolving AI Agents Will Revolutionize Luxury Clienteling and Discovery
New self-evolving search agents (SE-Search) and meta-RL frameworks (MAGE) enable AI that learns from customer interactions, improving product discovery and personalized service over time. This moves beyond static chatbots to create adaptive, strategic shopping assistants.
RxnNano: How a Tiny AI Model Outperforms Giants in Chemical Discovery
Researchers have developed RxnNano, a compact 0.5B-parameter AI model that outperforms models ten times larger in predicting chemical reactions. Using innovative training techniques that prioritize chemical understanding over brute-force scaling, it achieves 23.5% better accuracy on key benchmarks for drug discovery applications.
XtalPi's Profit Milestone Signals AI's Transformative Impact on Pharmaceutical Discovery
Chinese AI drug discovery firm XtalPi projects its first annual profit in 2025 following a 193% revenue surge, marking a pivotal moment for AI-driven pharmaceutical research. The company's turnaround demonstrates the commercial viability of AI in accelerating drug development pipelines.
Lilly's AI Factory: How a 9,000+ GPU SuperPOD is Rewriting Pharmaceutical Discovery
Eli Lilly has launched 'LillyPod,' the world's most powerful privately-owned AI factory for drug discovery. Powered by NVIDIA's new DGX B300 systems with over 1,000 Blackwell Ultra GPUs, it promises to accelerate medical breakthroughs at unprecedented scale.
ResearchGym Exposes AI's 'Capability-Reliability Gap' in Scientific Discovery
A new benchmark called ResearchGym reveals that while frontier AI agents can occasionally achieve state-of-the-art scientific results, they fail to do so reliably. In controlled evaluations, agents completed only 26.5% of research sub-tasks on average, highlighting critical limitations in autonomous scientific discovery.
AI Crosses the Rubicon: From Scientific Tool to Active Discovery Partner
This week marked a paradigm shift as AI systems transitioned from research tools to active participants in scientific discovery. OpenAI's GPT-5.2 Pro helped conjecture a new formula in particle physics, while Google's Gemini 3 Deep Think achieved unprecedented results on reasoning benchmarks. These developments signal AI's growing capacity for genuine scientific contribution.
Beyond Simple Search: How Advanced Image Retrieval Transforms Luxury Discovery
New research reveals major flaws in current visual search tech. For luxury retail, this means missed sales from poor multi-item inspiration and inconsistent results. A new benchmark and method promise more accurate, nuanced product discovery.
DrugPlayGround Benchmark Tests LLMs on Drug Discovery Tasks
A new framework called DrugPlayGround provides the first standardized benchmark for evaluating large language models on key drug discovery tasks, including predicting drug-protein interactions and chemical properties. This addresses a critical gap in objectively assessing LLMs' potential to accelerate pharmaceutical research.
Optimizing Luxury Discovery: A Smarter Pre-Ranking Engine for Personalization
New research tackles inefficiency in recommendation pipelines by intelligently separating 'easy' from 'hard' customer matches. This heterogeneity-aware pre-ranking can boost personalization accuracy while controlling computational costs, directly applicable to luxury product discovery and clienteling.
Anthropic Reportedly Deploys AI Model for Zero-Day Vulnerability Discovery
Anthropic has reportedly deployed a frontier AI model for discovering zero-day software vulnerabilities. The model is claimed to have found flaws in code audited by humans for decades.
Agentic AI in Beauty: How ChatGPT Is Reshaping Discovery, Trust, and Conversion
The article explores how conversational AI, particularly ChatGPT, is being deployed in the beauty sector to transform the customer journey. It moves beyond simple Q&A to act as an agent that proactively guides users, personalizes recommendations, and builds trust to drive conversion.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
Beyond Basic Browsing: Adaptive Multimodal AI for Next-Gen Luxury Discovery
A new AI model, CAMMSR, dynamically fuses image, text, and sequence data to understand nuanced client preferences. For luxury retail, this enables hyper-personalized recommendations that adapt to a client's evolving taste across categories, boosting engagement and conversion.
Bridging Language and Logic: How LLMs Are Revolutionizing Causal Discovery
Researchers introduce DMCD, a novel framework that combines LLM semantic reasoning with statistical validation to uncover causal relationships from data. This hybrid approach outperforms traditional methods on real-world benchmarks, promising more accurate AI-driven decision-making.
AI Firms Target Biotech for High-Impact, High-Margin Applications
A trend analysis notes AI companies are shifting focus to biotech, where accurate prediction models can be monetized through drug discovery and synthetic biology, creating a new competitive frontier.
BloClaw: New AI4S 'Operating System' Cuts Agent Tool-Calling Errors to 0.2% with XML-Regex Protocol
Researchers introduced BloClaw, a unified operating system for AI-driven scientific discovery that replaces fragile JSON tool-calling with a dual-track XML-Regex protocol, cutting error rates from 17.6% to 0.2%. The system autonomously captures dynamic visualizations and provides a morphing UI, benchmarked across cheminformatics, protein folding, and molecular docking.
OpenAI Scales Back ChatGPT Instant Checkout, Pivots to Merchant Apps
OpenAI is scaling back its Instant Checkout feature for ChatGPT after it failed to drive significant sales. The company will now focus on letting merchants use their own checkout within ChatGPT apps, prioritizing discovery over transaction.
Anthropic Launches Dedicated Science Blog to Chronicle AI Research and Applications
Anthropic has launched a new Science Blog to publish its research and case studies on using AI to accelerate scientific discovery, aligning with its mission to increase the pace of scientific progress.
OpenAI's 'Autonomous AI Researchers' Vision Sparks Debate on Biology's 'ChatGPT Moment'
A tweet highlights OpenAI's repeated references to 'autonomous AI researchers' as signaling a 'ChatGPT moment for biology,' suggesting AI could accelerate drug discovery by orders of magnitude. The claim draws a direct analogy to AlphaFold's impact on structural biology.